NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
23/10/2024
Voltar para busca
Dado oficial do USPTO
LEUKOSTRAT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
LEUKOSTRAT
ST13
US500000086560545Classe
1, 5, 42, 44
Pedido
86560545
Registro
5628108
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
11/07/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
11/03/2015
Data de registro
11/12/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/10/2024
Última transação
11/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
12/02/2010
Primeiro uso no comércio
12/02/2010
Código do desenho
4
Tipo de titular
03
Localização do titular
SAN DIEGO, CA
Examinador
SOUDERS, MICHAEL
Localização atual
Historical data usage
Titulares e representantes
Titulares
INVIVOSCRIBE, INC.
Invivoscribe Technologies, Inc.
Representantes
Sarah W. Matthews Dentons Durham Jones Pinegar
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Reagents for scientific and research usebuffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in PCRDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in PCRDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for researchclinical researchlaboratory research use
Classe 5
Assays for the treatment or diagnosis of disease; medical diagnostic reagentsbuffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in PCRDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; medical diagnostic kits comprised of buffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in PCRDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatmentmonitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids
Classe 42
DNA analysis services for scientific research purposesDNA sequencingbioinformatics analysisinterpretation of biological DNA data generated from reagents and assays
Classe 44
DNA screening for medical purposesDNA sequencingbioinformatics analysisinterpretation of biological DNA data generated from reagents and assays
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
23/10/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/10/2024
E815
TEAS SECTION 8 & 15 RECEIVED
30/04/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/12/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/12/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/11/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/11/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/10/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/10/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/09/2018
GNRT
NON-FINAL ACTION E-MAILED
24/09/2018
CNRT
SU - NON-FINAL ACTION - WRITTEN
24/09/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
13/09/2018
IUAF
USE AMENDMENT FILED
11/09/2018
EISU
TEAS STATEMENT OF USE RECEIVED
11/09/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/09/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17/04/2018
EX5G
SOU EXTENSION 5 GRANTED
16/04/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/04/2018
EXT5
SOU EXTENSION 5 FILED
30/03/2018
EEXT
SOU TEAS EXTENSION RECEIVED
30/03/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/03/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/03/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28/09/2017
EX4G
SOU EXTENSION 4 GRANTED
26/09/2017
EXT4
SOU EXTENSION 4 FILED
26/09/2017
EEXT
SOU TEAS EXTENSION RECEIVED
26/09/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
31/03/2017
EX3G
SOU EXTENSION 3 GRANTED
29/03/2017
EXT3
SOU EXTENSION 3 FILED
29/03/2017
EEXT
SOU TEAS EXTENSION RECEIVED
29/03/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27/10/2016
EX2G
SOU EXTENSION 2 GRANTED
26/10/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
26/10/2016
EXT2
SOU EXTENSION 2 FILED
04/10/2016
EEXT
SOU TEAS EXTENSION RECEIVED
04/10/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29/03/2016
EX1G
SOU EXTENSION 1 GRANTED
25/03/2016
EXT1
SOU EXTENSION 1 FILED
25/03/2016
EEXT
SOU TEAS EXTENSION RECEIVED
25/03/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/10/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/08/2015
PUBO
PUBLISHED FOR OPPOSITION
11/08/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/07/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/07/2015
ALIE
ASSIGNED TO LIE
02/07/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/06/2015
DOCK
ASSIGNED TO EXAMINER
16/06/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/03/2015
NWAP
NEW APPLICATION ENTERED
14/03/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LEUKOSTRAT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.